Dissociable influences of NR2B-receptor related neural transmission on functions of distinct associative basal ganglia circuits

NeuroImage

Volumn 52, Issue 1, 2010, Pages 309-315

  Beste, Christian ^a   Baune, Bernhard T ^b   Domschke, Katharina ^c   Falkenstein, Michael ^d   Konrad, Carsten ^c,e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Basal ganglia; Error monitoring; Event related potentials; GRIN2B; NR2B; Response inhibition

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR;

ADULT; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NEUROANATOMY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADAPTIVE BEHAVIOR; DNA SEQUENCE; EVOKED RESPONSE; EXECUTIVE FUNCTION; GENETIC POLYMORPHISM; GENETICS; INHIBITION (PSYCHOLOGY); METABOLISM; MISSENSE MUTATION; NERVE CELL; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SYNAPTIC TRANSMISSION; TIME; YOUNG ADULT;

ADULT; BASAL GANGLIA; EVOKED POTENTIALS; EXECUTIVE FUNCTION; FEEDBACK, PSYCHOLOGICAL; FEMALE; GENOTYPE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MUTATION, MISSENSE; NEURAL PATHWAYS; NEURONS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; RECEPTORS, N-METHYL-D-ASPARTATE; SEQUENCE ANALYSIS, DNA; SYNAPTIC TRANSMISSION; TIME FACTORS; YOUNG ADULT;

EID: 77953285667     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.04.022     Document Type: Article

References (68)

1. Arning L., Kraus P.H., Valentin S., Saft C., Andrich J., Epplen J.T. NR2A and NR2B receptor gene variations modify age at onset in Huntington's disease. Neurogenetics 2005, 6:25-28.
2. Arning L., Saft C., Wieczorek S., Andrich J., Kraus P.H., Epplen J.T. NR2A and NR2B gene variations modify age at onset in Huntington's disease in a sex-specific manner. Hum. Genet. 2007, 122:175-182.
3. Aron A.R., Robbins T.W., Poldrack R.A. Inhibition and the right inferior frontal cortex. Trends. Cogn. Sci. 2004, 8:170-177.
4. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci. 2004, 5:373-384.
5. Bekker E.M., Kenemans J.L., Verbaten M.N. Source analysis of the N2 in a cued Go/Nogo task. Brain Res. Cogn. Brain Res. 2005, 22:221-231.
6. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Error processing in Huntington's disease. PLoS ONE 2006, 86.
7. Beste C., Saft C., Güntürkün O., Falkenstein M. Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention. J. Neurosci. 2008, 28:11695-11702.
8. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Response inhibition in Huntington's disease-a study using ERPs and sLORETA. Neuropsychologia 2008, 46:1279-1289.
9. Beste C., Saft C., Konrad C., Andrich J., Habbel A., Schepers I., Jansen A., Pfleiderer B., Falkenstein M. Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry. Hum. Brain Mapp. 2008, 29:121-130.
10. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis. J. Neurophysiol. 2008, 99:213-233.
11. Beste C., Dziobek I., Hielscher H., Willemssen R., Falkenstein M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. Eur. J. NeuroSci. 2009, 29:855-860.
12. Beste C., Willemssen R., Saft C., Falkenstein M. Error processing in normal aging and in basal ganglia disorders. Neuroscience 2009, 159:143-149.
13. Beste C., Willemssen R., Saft C., Falkenstein M. Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. Neuropsychologia 2010, 48:366-373.
14. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition. Neuroscience 2010, 166:178-184.
15. Blanchet F., Gauchy C., Perez S., Soubrie P., Glowinski J., Kemel M.L. Distinct modifications by neurokinin1 (SR14033) and neurokinin2 (SR48968) tachykinin receptor antagonists of the N-methyl-d-aspartate-evoked release of achethylcholine in striosomes and matrix of the rat striatum. Neuroscience 1998, 85:1025-1036.
16. Bokura H., Yamaguchi S., Kobayashi S. Electrophysiological correlates for response inhibition in a Go/Nogo task. Clin. Neurophysiol. 2001, 112:2224-2232.
17. Bordelon Y.M., Mackenzie L., Chesselet M.F. Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum. J. Comp. Neurology. 1999, 412:38-50.
18. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends. Cogn. Sci. 2000, 4:215-222.
19. Chambers C.D., Bellgrove M.A., Stokes M.G., Henderson T.R., Garavan H., Robertson I.H., Morris A.P., Mattingley J.B. Executive "brake failure" following deactivation of human frontal lobe. J. Cogn. Neurosci. 2006, 18:444-453.
20. Cherlyn, S. Y. T., Woon, P. S., Liu, J. J., Ong, W. Y., Tsai, G. C., Sim, K., 2010. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance. Neurosci Biobehav Rev [Electronic publication ahead of print].
21. Chudasama Y., Robbins T.W. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol. Psychol. 2006, 73:19-38.
22. Corbetta M., Shulman G.L. Control of goal-directed and stimulus-driven attention in the brain. Nat. Rev. Neurosci. 2002, 3:201-215.
23. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 2006, 26:365-384.
24. Debener S., Ullsperger M., Siegel M., Fiehler K., von Cramon D.Y., Engel A.K. Trial-by-trial coupling of concurrent electroencephalogram and functional magnetic resonance imaging identifies the dynamics of performance monitoring. J. Neurosci. 2005, 25:11730-11737.
25. Dorval K.M., Wigg K.G., Crosbie J., Tannock R., Kennedy J.L., Ickowicz A., Pathare T., Malone M., Schachar R., Barr C.L. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes .Brain. Behav. 2007, 6:444-452.
26. Duan J., Wainwright M., comeron J., Saitou N., Sanders A., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 12:205-216.
27. Dure L.S., Young A.B., Penney J.B. Compartmentalization of excitatory amino acid receptors in human striatum. Proc. Natl. Acad. Sci. U S A 1992, 89:7688-7692.
28. Eblen F., Graybiel A.M. Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J. Neurosci. 1995, 15:5999-6013.
29. Falkenstein M. Inhibition, conflict and the Nogo-N2. Clin. Neurophysiol. 2006, 117:1638-1640.
30. Falkenstein M., Hohnsbein J., Hoormann J., Blanke L. Effects of crossmodal divided attention on late ERP components. II. Error processing in choice reaction tasks. Electroencephalogr. Clin. Neurophysiol. 1991, 78:447-455.
31. Falkenstein M., Hoormann J., Hohnsbein J. ERP components in Go/Nogo tasks and their relation to inhibition. Acta. Psychol. (Amst.) 1999, 101:267-291.
32. Falkenstein M., Hoormann J., Christ S., Hohnsbein J. ERP components on reaction errors and their functional significance: a tutorial. Biol. Psychol. 2000, 51:87-107.
33. Gale J.T., Amirovin R., Williams Z.M., Flaherty A.W., Eskandar E.N. From synchrony to cacophony: pathophysiology of the human basal ganglia in Parkinson disease. Neurosci. Biobehav. Rev. 2008, 32:378-387.
34. Garavan H., Ross T.J., Murphy K., Roche R.A., Stein E.A. Dissociable executive functions in dynamic control of behaviour: inhibition, error detection, and correction. Neuroimage 2002, 17:1820-1829.
35. Gehring W.J., Goss B., Coles M.G.H., Meyer D.E., Donchin E. A neural system for error detection and compensation. Psychol. Sci. 1993, 4:385-390.
36. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 1983, 55:468-484.
37. Gurney K., Prescott T.J., Wickens J.R., Redgrave P. Computational models of the basal ganglia: from robots to membranes. Trends. Cogn. Sci. 2004, 27:453-459.
38. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003, 26:317-330.
39. Hampshire A., Thompson R., Duncan J., Owen A.M. Selective tuning of the right inferior frontal gyrus during target detection. Cogn. Affect. Behav. Neurosci. 2009, 9:103-112.
40. Holroyd C.B., Coles M.G. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol. Rev. 2002, 109:679-709.
41. Kopp B., Rist F., Mattler U. N200 in the flanker task as a neurobehavioural tool for investigating executive control. Psychophysiology 1996, 33:282-294.
42. Küppenbender K., Standaert D.G., Feuerstein T.J., Penney J.B., Young A.B., Landwehrmeyer G.B. Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J. Comp. Neurol. 2000, 419:407-421.
43. Lavric A., Pizzagalli D.A., Forstmeier S. When "go" and "nogo" are equally frequent: ERP components and cortical tomography. Eur. J. NeuroSci. 2004, 20:2483-2488.
44. Lee J.Y., Lee E.K., Park S.S., Lim J.Y., Kim H.J., Kim J.S., Jeon B.S. Association of DDR3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov. Disord. 2009, 24:1803-1810.
45. Liddle P.F., Kiehl K.A., Smith A.M. Event-related fMRI study of response inhibition. Hum. Brain Mapp. 2001, 12:100-109.
46. Loftis J.M., Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and chemical implications. Pharmacol. Ther. 2003, 97:55-85.
47. Ludwig K.U., Roeske D., Kerms S., Schumacher J., Warnke A., Plume E., Neuhoff N., Bruder J., Remschmidt H., Schulte-Körne G., Müller-Myhsok B., Nöthen M.M., Hoffmann P. Variation in GRIN2B contributes to weak performance in verbal short-term memory in children with dyslexia. Am. J. Med. Genet. B. Neuopsychiatr. Genet. 2010, 153:503-511.
48. Martin L.J., Blackstone C.D., Huganir R.L., Price D.L. The striatal mosaic in primates: striosomes and matrix are differentially enriched in ionotropic glutamate receptor subunits. J. Neurosci. 1993, 13:782-792.
49. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17:2921-2927.
50. Nieuwenhuis S., Yeung N., van den Wildenberg W., Ridderinkhof K.R. Electrophysiological correlates of anterior cingulate function in a go-no-go task:effects of response conflict and trial type frequency. Cogn. Affect. Behav. Neurosci. 2003, 3:17-26.
51. Nishiguchi N., Shirakawa O., Ono H., Hashimoto T., Maeda K. Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am. J. Psychiatry. 2000, 157:1329-1331.
52. Oeth, P., Beaulieu, M., Park, C., Kosman, D., del Mistro, G., van den Boom, D., Jurinke, C., 2007. "iPLEX™ Assay: Increased Plexing Efficiency and Flexibility for MassARRAY System Through Single Base Primer Extension with Mass-Modified Terminators." http://www.agrf.org.au/docstore/snp/iPlex.pdf.
53. Pennartz C.M.A., Berke J.D., Graybiel A.M., Ito R., Lansink C., van der Meer M., Redish A.D., Smith K.S., Voorn P. Corticostriatal interactions during learning, memory processing, and decision making. J. Neurosci. 2009, 29:12831-12838.
54. Quin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., Bao J., Thang Z., He L. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur. J. Hum. Genet. 2005, 13:807-814.
55. Rabbitt P.M. Error and error correction in choice-response tasks. Nature 1966, 212:438.
56. Ridderinkhof K.R., Ullsperger M., Crone E.A., Nieuwenhuis S. The role the medial frontal cortex in cognitive control. Science 2004, 306:443-447.
57. Roche R.A., Garavan H., Foxe J.J., O'Mara S.M. Individual differences discriminate event-related potentials but not performance during response inhibition. Exp. Brain Res. 2005, 160:60-70.
58. Rolls E.T., Grabenhorst F. The orbitofrontal cortex and beyond: from affect to decision-making. Prog. Neurobiol. 2008, 86:216-244.
59. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S., Graybiel A.M., Goto S. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dyskinesia. Proc. Natl. Acad. Sci. U S A 2008, 105:12551-12556.
60. Schmajuk M., Liotti M., Busse L., Woldorff M.G. Electrophysiological activity underlying inhibitory control processes in normal adults. Neuropsychologia 2006, 44:384-395.
61. Schoenbaum G., Roesch M., Stalnaker T.A., Takahashi Y.K. A new perspective on the role of the orbitofrontal cortex in adaptive behaviour. Nat. Rev. Neurosci. 2009, 10:885-892.
62. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 2004, 74:1-58.
63. Tang Y.-P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69.
64. Van Dongen Y.C., Deniau J.M., Pennartz C.M., Galis-de Graaf Y., Voorn P., Thierry A.M., Groenewegen H.J. Anatomical evidence for direct connections between the shell and core subregions of the rat nucleus accumbens. Neuroscience 2005, 136:1049-1071.
65. Villmann C., Becker C.M. On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 2007, 13:594-615.
66. Wallis J.D. Orbitofrontal cortex and its contribution to decision-making. Annu. Rev. Neurosci. 2007, 30:31-56.
67. Wild-Wall N., Willemssen R., Falkenstein M., Beste C. Time estimation in healthy ageing and neurodegenerative basal ganglia disorders. Neurosci Lett 2008, 442:34-38.
68. Zeron M.M., Hansson O., Chen N., Wellington C.L., Leavitt B.R., Brundin P., Hayden M.R., Raymond L.A. Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 2002, 33:849-860.